Rhodes Pharmaceuticals, L.P. recalls Aptensio XR (methylphenidate HCl extended-release) capsules 15 mg Rx Only 90-count bottle. Marketed by: Rhodes Pharmaceu
Recalled May 9, 2018 · FDA recall D-0710-2018 · Rhodes Pharmaceuticals, L.P
Hazard
Failed Dissolution Specification: Low dissolution outside of specifications · FDA Class III
Units
2454 bottles
Sold at
Nationwide within the USA
Description
Failed Dissolution Specification: Low dissolution outside of specifications
Product
Aptensio XR (methylphenidate HCl extended-release) capsules 15 mg Rx Only 90-count bottle. Marketed by: Rhodes Pharmaceuticals L.P., Coventry, RI 02816. Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834. NDC 42858-402-45
Manufacturer(s)
Rhodes Pharmaceuticals, L.P.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →